Biomimetic fusion nanosystem from ginger exosomes and tumor cell membranes: boosting PLK1-targeted therapy in BRCA-heterogeneous HGSOC

Xue Zhou, Yutang Huang, Chenyi Li, Wenlu Mo, Weifeng Xia, Ruiqin Du, Lanxiang Wu, Hongbo Zhao · 2026

Read Biomimetic fusion nanosystem from ginger exosomes and tumor cell membranes: boosting PLK1-targeted therapy in BRCA-heterogeneous HGSOC by Xue Zhou, Yutang Huang, Chenyi Li, Wenlu Mo, Weifeng Xia, Ruiqin Du, Lanxiang Wu, Hongbo Zhao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13528168.txt.

Description

Xue Zhou and seven colleagues build a timed, targeted drug system for a deadly ovarian cancer in a 2026 study. The cancer is high-grade serous carcinoma. The target is PLK1, a cell division switch. Its blocker, Bi2536, halts the cycle and triggers cell death in lab tests. The team noticed PLK1 levels rise and fall with the daily clock.

They wrapped the drug in a shell fused from ginger vesicles and tumor cell skins. The shell homes to the tumor and adds chemical attack of its own. In mouse grafts the system beat free drug clearly. Giving doses at the daily PLK1 peak helped even more. The authors unite three ideas: a strong target, a smart carrier, and clock timing. They pitch the mix for cancers where gene-based options run out.

Catalog record

CREATORXue Zhou, Yutang Huang, Chenyi Li, Wenlu Mo, Weifeng Xia, Ruiqin Du, Lanxiang Wu, Hongbo Zhao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68531
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13528168

Browse the full library · About the Tower of Babel